我们需要什么样的随机试验？ - Suppr

What kind of randomized trials do we need?

作者信息

Zwarenstein Merrick, Treweek Shaun

机构信息

Centre for Health Services Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Rm. G1-06, 2075 Bayview Ave., Toronto, ON M4N 3M5.

出版信息

CMAJ. 2009 May 12;180(10):998-1000. doi: 10.1503/cmaj.082007. Epub 2009 Apr 16.

DOI:10.1503/cmaj.082007

PMID:19372438

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2679816/

Abstract

摘要

相似文献

What kind of randomized trials do we need?

CMAJ. 2009 May 12;180(10):998-1000. doi: 10.1503/cmaj.082007. Epub 2009 Apr 16.

Overhauling clinical trials.

Nat Biotechnol. 2007 Mar;25(3):287-92. doi: 10.1038/nbt0307-287.

Expedited approval programs at the Food and Drug Administration.

Clin Trials. 2018 Jun;15(3):217-218. doi: 10.1177/1740774518770653.

Challenges and opportunities for conducting neonatal clinical trials in low- and middle-income countries.

J Perinatol. 2019 Sep;39(Suppl 1):1-2. doi: 10.1038/s41372-019-0470-2.

Controversy trails adaptive clinical trials.

J Natl Cancer Inst. 2012 Sep 19;104(18):1347-8. doi: 10.1093/jnci/djs404. Epub 2012 Sep 14.

FDA and pharma seek better ways to assess drug safety, efficacy in clinical trials.

JAMA. 2012 Jun 27;307(24):2576-7. doi: 10.1001/jama.2012.6684.

The continuing unethical use of placebo controls.

N Engl J Med. 1994 Aug 11;331(6):394-8. doi: 10.1056/NEJM199408113310611.

Mechanical Cardiac Support 2000: Current applications and future trial design.

J Thorac Cardiovasc Surg. 2001 Mar;121(3):418-24. doi: 10.1067/mtc.2001.113857.

Issues of study design and data analysis.

Inflamm Bowel Dis. 1998 May;4(2):109-111; discussion 111-3. doi: 10.1097/00054725-199805000-00012.

Research for practitioners or research for researchers?

J Am Coll Dent. 1998 Fall;65(3):2-4.

引用本文的文献

Implementation fidelity in a multifaceted program to foster rational antibiotics use in primary care: an observational study.

BMC Med Res Methodol. 2022 Sep 19;22(1):243. doi: 10.1186/s12874-022-01725-3.

Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis.

Neurol Res Int. 2021 Jul 15;2021:6679197. doi: 10.1155/2021/6679197. eCollection 2021.

Child and Adolescent Mental Health and Resilience-Focussed Interventions: A Conceptual Analysis to Inform Future Research.

Int J Environ Res Public Health. 2021 Jul 8;18(14):7315. doi: 10.3390/ijerph18147315.

A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.

J Clin Epidemiol. 2021 Sep;137:45-57. doi: 10.1016/j.jclinepi.2021.03.021. Epub 2021 Mar 28.

Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study.

BMJ. 2021 Mar 3;372:n450. doi: 10.1136/bmj.n450.

Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.

JAMA Pediatr. 2020 Apr 1;174(4):332-340. doi: 10.1001/jamapediatrics.2019.5863.

The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.

Trials. 2019 Dec 23;20(1):765. doi: 10.1186/s13063-019-3899-x.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

Research-grade data in the real world: challenges and opportunities in data quality from a pragmatic trial in community-based practices.

J Am Med Inform Assoc. 2019 Aug 1;26(8-9):847-854. doi: 10.1093/jamia/ocz062.

Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol.

BMC Med Ethics. 2018 Nov 20;19(1):90. doi: 10.1186/s12910-018-0332-z.

本文引用的文献

A pragmatic resolution.

J Clin Epidemiol. 2009 May;62(5):495-8. doi: 10.1016/j.jclinepi.2008.08.014.

The practicalists' response.

J Clin Epidemiol. 2009 May;62(5):489-94. doi: 10.1016/j.jclinepi.2008.08.013.

Why we will remain pragmatists: four problems with the impractical mechanistic framework and a better solution.

J Clin Epidemiol. 2009 May;62(5):485-8. doi: 10.1016/j.jclinepi.2008.08.015.

Explaining pragmatic trials to pragmatic policymakers.

J Clin Epidemiol. 2009 May;62(5):476-8. doi: 10.1016/j.jclinepi.2008.06.021.

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

J Clin Epidemiol. 2009 May;62(5):464-75. doi: 10.1016/j.jclinepi.2008.12.011.

Improving the reporting of pragmatic trials: an extension of the CONSORT statement.

BMJ. 2008 Nov 11;337:a2390. doi: 10.1136/bmj.a2390.

STREPTOMYCIN treatment of pulmonary tuberculosis.

Br Med J. 1948 Oct 30;2(4582):769-82.

A new 'mechanistic-practical" framework for designing and interpreting randomized trials.

J Clin Epidemiol. 2009 May;62(5):479-84. doi: 10.1016/j.jclinepi.2008.02.009. Epub 2008 May 12.

[A critical review of the pragmatic clinical trial].

Med Clin (Barc). 2003 Sep 27;121(10):384-8. doi: 10.1016/s0025-7753(03)73957-8.

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

JAMA. 2003 Sep 24;290(12):1624-32. doi: 10.1001/jama.290.12.1624.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

What kind of randomized trials do we need?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献